BVSBioventus Inc.
$12.70+91% 1Y
$12.70
$6.5152 weeks$15.30
BVS in its own filings
BVS's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
119
Events found in the filings · across 460 filings · the record starts in 2020
- Hard flags
- 1
Hard flags
- Most recent filing
- Aug 5, 2026
Most recent filing · Form 10-Q
- Record starts
- Nov 2, 2020
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 3, 2026
- Late periodic report3 occurrences
- 2023-05-11
- SEC comment-letter activity11 occurrences
- 2024-11-01
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 5, 2026As previously announced, following receipt of a recent unsolicited acquisition proposal from a party interested in acquiring the Company and multiple other expressions of interest, the Company’s Board of Directors (the “Board”) established a committee of independent directors, which, with the assistance of independent …Earnings release · Form 8-K
- May 6, 2026Bioventus Reports First Quarter Financial Results.Earnings release · press release
- Mar 5, 2026Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results.Earnings release · press release
- Nov 17, 2025On November 14, 2025, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) appointed Ajay Dhankhar, PhD, to the Board as a Class II director effective on November 14, 2025.Director or officer change · Form 8-K
- Nov 4, 2025Bioventus Reports Third Quarter Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Medical Devices
Ranks #18 of 51 by RyuScore